[Estrogen substitution and endometrial carcinoma].
D000368:Aged; D004715:Endometriosis / Q000139:chemically induced*; D004958:Estradiol / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects* / Q000627:therapeutic use; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects; D004970:Estrone / Q000009:adverse effects; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D012107:Research Design; D014594:Uterine Neoplasms / Q000139:chemically induced*
D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D004970:Estrone; D004958:Estradiol
Substitutie met oestrogenen en endometriumcarcinoom.